1066575

Taro Pharmaceuticals U.S.A., Inc. — FEI 2435212

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 27, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hawthorne, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)